Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Project

Synergistic drug interactions with CDK12-controlled DNA damage response signaling as potential immunomodulatory therapy for high-risk neuroblastoma

Outputs and Outcomes

Code

DOCT/012628

Duration

11 October 2024 → 21 September 2025 (Ongoing)

Doctoral researcher

Rizwan Ahmad

Research disciplines

No data available

Project description

No data available